Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carrageenan-Containing Gel for Prevention of HPV Infection
NCT02382419Phase 2Withdrawn
- Sponsor
- Rutgers University
- Start
- Feb 2016
- Primary completion
- Feb 2019
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human papillomavirus infection comparing Carrageenan Gel with Placebo Gel (2 arms). Primary endpoint: Rate of incident cervical HPV infection at 1 year. Planned start Feb 2016; status: withdrawn.
02
Drugs
Iota-carrageenan
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT02382419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02382419.